Overview
Localized dystrophic epidermolysis bullosa, acral form (also known as acral dystrophic epidermolysis bullosa or dystrophic EB, pretibial type in some classifications) is a rare inherited skin fragility disorder belonging to the dystrophic epidermolysis bullosa (DEB) spectrum. It is caused by mutations in the COL7A1 gene, which encodes type VII collagen — a critical structural protein that forms anchoring fibrils at the dermal-epidermal junction. Deficiency or dysfunction of type VII collagen leads to impaired adhesion between the epidermis and dermis, resulting in blistering and skin erosions predominantly affecting the acral (distal extremity) areas such as the hands and feet. Clinically, this form of DEB is characterized by mechanically induced blisters, erosions, and scarring that are largely confined to the hands, feet, and sometimes the nails. Nail dystrophy is a common feature, and milia (small white cysts) may develop at sites of healed blisters. Unlike more severe generalized forms of dystrophic epidermolysis bullosa, the acral form tends to have a milder course with limited skin involvement and generally does not affect mucosal surfaces or internal organs to a significant degree. However, repeated trauma to the extremities can lead to progressive scarring and functional impairment over time. There is currently no cure for localized dystrophic epidermolysis bullosa, acral form. Management is primarily supportive and focuses on wound care, prevention of trauma and infection, and protection of vulnerable skin areas. Careful bandaging, use of padded footwear, and avoidance of friction are important preventive strategies. Wound infections should be treated promptly with appropriate antibiotics. Genetic counseling is recommended for affected individuals and their families. Research into gene therapy, protein replacement therapy, and other molecular approaches for dystrophic EB is ongoing but has not yet yielded approved treatments specific to this subtype.
Also known as:
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Localized dystrophic epidermolysis bullosa, acral form.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Localized dystrophic epidermolysis bullosa, acral form at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Localized dystrophic epidermolysis bullosa, acral form.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Localized dystrophic epidermolysis bullosa, acral form.
Community
No community posts yet. Be the first to share your experience with Localized dystrophic epidermolysis bullosa, acral form.
Start the conversation →Latest news about Localized dystrophic epidermolysis bullosa, acral form
No recent news articles for Localized dystrophic epidermolysis bullosa, acral form.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Localized dystrophic epidermolysis bullosa, acral form
What is Localized dystrophic epidermolysis bullosa, acral form?
Localized dystrophic epidermolysis bullosa, acral form (also known as acral dystrophic epidermolysis bullosa or dystrophic EB, pretibial type in some classifications) is a rare inherited skin fragility disorder belonging to the dystrophic epidermolysis bullosa (DEB) spectrum. It is caused by mutations in the COL7A1 gene, which encodes type VII collagen — a critical structural protein that forms anchoring fibrils at the dermal-epidermal junction. Deficiency or dysfunction of type VII collagen leads to impaired adhesion between the epidermis and dermis, resulting in blistering and skin erosions
At what age does Localized dystrophic epidermolysis bullosa, acral form typically begin?
Typical onset of Localized dystrophic epidermolysis bullosa, acral form is neonatal. Age of onset can vary across affected individuals.